These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 35901339)
1. A Double-Blind, Placebo-Controlled Randomized Phase IIa Study: Evaluating the Effect of Curcumin for Treatment of Cancer Anorexia-Cachexia Syndrome in Solid Cancer Patients. Chaiworramukkul A; Seetalarom K; Saichamchan S; Prasongsook N Asian Pac J Cancer Prev; 2022 Jul; 23(7):2333-2340. PubMed ID: 35901339 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of Curcumin on Treating Cancer Anorexia-Cachexia Syndrome in Locally or Advanced Head and Neck Cancer: A Double-Blind, Placebo-Controlled Randomised Phase IIa Trial (CurChexia). Thambamroong T; Seetalarom K; Saichaemchan S; Pumsutas Y; Prasongsook N J Nutr Metab; 2022; 2022():5425619. PubMed ID: 35694030 [TBL] [Abstract][Full Text] [Related]
3. Mirtazapine in Cancer-Associated Anorexia and Cachexia: A Double-Blind Placebo-Controlled Randomized Trial. Hunter CN; Abdel-Aal HH; Elsherief WA; Farag DE; Riad NM; Alsirafy SA J Pain Symptom Manage; 2021 Dec; 62(6):1207-1215. PubMed ID: 34051293 [TBL] [Abstract][Full Text] [Related]
4. The role of thalidomide and placebo for the treatment of cancer-related anorexia-cachexia symptoms: results of a double-blind placebo-controlled randomized study. Yennurajalingam S; Willey JS; Palmer JL; Allo J; Del Fabbro E; Cohen EN; Tin S; Reuben JM; Bruera E J Palliat Med; 2012 Oct; 15(10):1059-64. PubMed ID: 22880820 [TBL] [Abstract][Full Text] [Related]
5. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group. ; Strasser F; Luftner D; Possinger K; Ernst G; Ruhstaller T; Meissner W; Ko YD; Schnelle M; Reif M; Cerny T J Clin Oncol; 2006 Jul; 24(21):3394-400. PubMed ID: 16849753 [TBL] [Abstract][Full Text] [Related]
6. Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials. Temel JS; Abernethy AP; Currow DC; Friend J; Duus EM; Yan Y; Fearon KC Lancet Oncol; 2016 Apr; 17(4):519-531. PubMed ID: 26906526 [TBL] [Abstract][Full Text] [Related]
7. The efficacy and safety of anamorelin for patients with cancer-related anorexia/cachexia syndrome: a systematic review and meta-analysis. Taniguchi J; Mikura S; da Silva Lopes K Sci Rep; 2023 Sep; 13(1):15257. PubMed ID: 37709824 [TBL] [Abstract][Full Text] [Related]
8. Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials. Garcia JM; Boccia RV; Graham CD; Yan Y; Duus EM; Allen S; Friend J Lancet Oncol; 2015 Jan; 16(1):108-16. PubMed ID: 25524795 [TBL] [Abstract][Full Text] [Related]
9. Anamorelin for the Treatment of Cancer Anorexia-Cachexia Syndrome. Dev R; Amano K; Naito T; Del Fabbro E Curr Oncol Rep; 2024 Jul; 26(7):762-772. PubMed ID: 38771469 [TBL] [Abstract][Full Text] [Related]
10. Pentoxifylline for treatment of cancer anorexia and cachexia? A randomized, double-blind, placebo-controlled trial. Goldberg RM; Loprinzi CL; Mailliard JA; O'Fallon JR; Krook JE; Ghosh C; Hestorff RD; Chong SF; Reuter NF; Shanahan TG J Clin Oncol; 1995 Nov; 13(11):2856-9. PubMed ID: 7595749 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of Yukgunja-Tang for treating anorexia in patients with cancer: The protocol for a pilot, randomized, controlled trial. Kang HJ; Jeong MK; Park SJ; Jun HJ; Yoo HS Medicine (Baltimore); 2019 Oct; 98(40):e16950. PubMed ID: 31577697 [TBL] [Abstract][Full Text] [Related]
12. A double-blind, placebo-controlled randomized trial of creatine for the cancer anorexia/weight loss syndrome (N02C4): an Alliance trial. Jatoi A; Steen PD; Atherton PJ; Moore DF; Rowland KM; Le-Lindqwister NA; Adonizio CS; Jaslowski AJ; Sloan J; Loprinzi C Ann Oncol; 2017 Aug; 28(8):1957-1963. PubMed ID: 28475678 [TBL] [Abstract][Full Text] [Related]
13. Brief versions of the FACIT-fatigue and FAACT subscales for patients with non-small cell lung cancer cachexia. Salsman JM; Beaumont JL; Wortman K; Yan Y; Friend J; Cella D Support Care Cancer; 2015 May; 23(5):1355-64. PubMed ID: 25351456 [TBL] [Abstract][Full Text] [Related]
14. Usage of megestrol acetate in the treatment of anorexia-cachexia syndrome in the elderly. Yeh SS; Lovitt S; Schuster MW J Nutr Health Aging; 2009 May; 13(5):448-54. PubMed ID: 19390752 [TBL] [Abstract][Full Text] [Related]
15. Alleviation of cancer anorexia and cachexia: studies of the Mayo Clinic and the North Central Cancer Treatment Group. Loprinzi CL; Ellison NM; Goldberg RM; Michalak JC; Burch PA Semin Oncol; 1990 Dec; 17(6 Suppl 9):8-12. PubMed ID: 2259930 [TBL] [Abstract][Full Text] [Related]
16. Anamorelin for cancer anorexia-cachexia syndrome: a systematic review and meta-analysis. Bai Y; Hu Y; Zhao Y; Yu X; Xu J; Hua Z; Zhao Z Support Care Cancer; 2017 May; 25(5):1651-1659. PubMed ID: 28074289 [TBL] [Abstract][Full Text] [Related]
17. Management of cancer anorexia/cachexia. Loprinzi CL Support Care Cancer; 1995 Mar; 3(2):120-2. PubMed ID: 7773579 [TBL] [Abstract][Full Text] [Related]
18. The emerging role of anamorelin hydrochloride in the management of patients with cancer anorexia-cachexia. Currow DC; Skipworth RJ Future Oncol; 2017 Aug; 13(20):1767-1783. PubMed ID: 28621564 [TBL] [Abstract][Full Text] [Related]
19. High-dose progestins for the treatment of cancer anorexia-cachexia syndrome: a systematic review of randomised clinical trials. Maltoni M; Nanni O; Scarpi E; Rossi D; Serra P; Amadori D Ann Oncol; 2001 Mar; 12(3):289-300. PubMed ID: 11332139 [TBL] [Abstract][Full Text] [Related]